Wikipedia -WSS

Wikipedia

author：fashion 2025-09-06 02:10:16 - browse：3

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Florida health officials providing scant details on measles cases

WSS

Menendez indictment could see pharma lose a key ally

Readout Newsletter: BridgeBio, Akero, and human embryo models

Researchers use wearables data and AI to predict preterm birth risk

Medicare drug price negotiation continues, as pharma counteroffers

How the Dana

Inequities make cancer less preventable for women: report

leisure time

Wikipedia

knowledge

New air purifier tech could be key to improving indoor air quality

Sudafed saga points to U.S. issues with evaluating older drugs

Peter Hotez and the public health issue of online harassment

Shingles, which affected Dianne Feinstein, is on the rise

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Data show record exodus of life scientists from academia

What does generative AI mean for health care? We asked experts

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Moonlake's readout produced a cash windfall. Risks remain

Why Talkspace is targeting Medicare, a tricky market

hotspot

How one patient went off dialysis — and others can too

Stem cell biologist probes earliest stages of human development

Biden's 'march

Covid vaccines: Private market messier than government rollout

For AI in health care standards, federal regulators join with industry group

Inequities make cancer less preventable for women: report

knowledge

focus

hotspot

focus